CD8A and primary cutaneous T-cell non-Hodgkin lymphoma: After discounting neoplastic T cells, SS patients had fewer CD8+ T cells and more myeloid cells and CTCL patients had fewer CD4−CD8− T cells than HCs (Figure 1E).